Anti-influenza drugs

Development of new drugs against influenza has been of great interest. Number of drugs show Anti-influenza properties, but may have altered effects for the use in clinic. These drugs target viral components and some target the host cell elements which help in the viral cycle, but related side effects are the disadvantages. As for now, four antiviral drugs have been discovered against influenza; zanamivir and oseltamivir which inhibit neuraminidase which act in both Influenza A and Influenza B, while rimantadine and amantadine block M2 passage of influenza A.

 

  • Clinical trials
  • Influenza and pneumonia
  • Influenza immunization
  • Ethical preparedness

Related Conference of Anti-influenza drugs

December 11-12, 2025

8th Annual Congress on Bacterial, Viral and Infectious Diseases

Prague, Czech Republic
December 15-16, 2025

7th Global Experts Meeting on Infectious Diseases

Barcelona, Spain
December 17-18, 2025

17th Global Conference on Nephrology and Infectious Diseases

Amsterdam, Netherlands
May 18-19, 2026

15th World Congress on Rare Diseases and Orphan Drugs

Prague, Czech Republic

Anti-influenza drugs Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in